Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CTIC | COLL | CALT | ||
Company | Cti Biopharm Corp | Collegium Pharma | Calliditas Therapeutics Ab ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 9.10 | 37.44 | 40.46 | ||
High | 9.10 | 39.28 | 40.80 | ||
Low | 9.09 | 37.32 | 39.20 | ||
Last | 9.09 | 38.78 | 40.03 | ||
Change | unch | +1.40 | +0.04 | ||
% Change | unch | +3.75% | +0.10% | ||
Volume | 11,420,900 | 360,500 | 6,000 | ||
20-Day Average Volume | 3,402,150 | 284,240 | 10,765 | ||
Previous Close | 9.09 | 37.38 | 39.99 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.06 | 37.21 | 40.35 | ||
20-Day Raw Stochastic | 88.89% | 88.12% | 32.35% | ||
20-Day Relative Strength | 80.92% | 59.70% | 53.66% | ||
Weighted Alpha | +5.50 | +65.63 | +43.04 | ||
Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
Last Month's Opinion | 48% Buy | 72% Buy | 80% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.22% since 06/15/23 | +7.13% since 09/11/24 | +0.63% since 09/10/24 | ||
Low | 9.07 on 06/20/23 | 36.13 on 09/12/24 | 39.04 on 09/13/24 | ||
High | 9.10 on 06/23/23 | 39.28 on 09/18/24 | 40.80 on 09/18/24 | ||
1-Month | |||||
%Chg | +1.11% since 05/23/23 | +9.98% since 08/16/24 | +1.81% since 08/16/24 | ||
Low | 8.98 on 05/24/23 | 35.07 on 09/10/24 | 39.04 on 09/13/24 | ||
High | 9.10 on 06/23/23 | 39.28 on 09/18/24 | 42.10 on 09/03/24 | ||
3-Month | |||||
%Chg | +111.40% since 03/23/23 | +20.62% since 06/18/24 | +2.51% since 06/18/24 | ||
Low | 4.01 on 04/06/23 | 31.12 on 06/20/24 | 35.77 on 08/15/24 | ||
High | 9.10 on 06/23/23 | 39.58 on 07/30/24 | 42.10 on 09/03/24 | ||
6-Month | |||||
%Chg | +61.46% since 12/23/22 | -1.45% since 03/18/24 | +81.54% since 03/18/24 | ||
Low | 4.01 on 04/06/23 | 30.42 on 05/10/24 | 16.00 on 04/16/24 | ||
High | 9.10 on 06/23/23 | 40.95 on 03/28/24 | 42.10 on 09/03/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,198,789 | 1,222,887 | 1,191,302 | ||
Shares Outstanding, K | 131,880 | 32,715 | 29,790 | ||
Annual Sales | 53,950,000 | 566,770,000 | 113,810,000 | ||
Annual Net Income | -92,990,000 | 48,160,000 | -43,960,000 | ||
Last Quarter Sales | 24,120,000 | 145,280,000 | 52,280,000 | ||
Last Quarter Net Income | -13,420,000 | 19,610,000 | -4,430,000 | ||
60-Month Beta | 0.83 | 0.94 | 1.77 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.10 on 05/15/23 | 1.62 on 08/08/24 | -0.16 on 08/13/24 | ||
Latest Earnings Date | 08/14/23 | 11/05/24 | 11/11/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 6.86 | 0.00 |